Also from this source

You just read:

Inhibrx Wins CARB-X Award Of Up To $6.0M To Accelerate Development Of Its Novel Antibody, INBRX-111, To Treat Pseudomonas Infections

News provided by

Inhibrx

Oct 31, 2017, 08:00 ET